BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6974071)

  • 1. Anti-albumin antibodies in chronic liver diseases: diagnostic significance of these antibodies in patients with conventional or immunosuppressive therapy.
    Lenkei R; Buligescu L; Belascu I; Pospai D; Dobre I
    Clin Exp Immunol; 1981 Feb; 43(2):381-9. PubMed ID: 6974071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new antigen/antibody system--the polymerized albumin and antialbumin antibodies.
    Lenkei R
    Med Interne; 1980; 18(2):129-47. PubMed ID: 6156487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH.
    Frazer IH; Kronborg IJ; Mackay IR
    Clin Exp Immunol; 1983 Oct; 54(1):213-8. PubMed ID: 6616969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [For which liver diseases is immunosuppressive therapy indicated?].
    Bannaski H
    Med Klin Prax; 1982 Aug; 77(16-17):66-71, 74. PubMed ID: 7132889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood amino acids in chronic HBsAg positive liver disease].
    De Marco F; Palmieri G; Capuano G; Gentile R; Nardone G; Parrilli G; Prantera T; Budillon G
    Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1576-81. PubMed ID: 6661322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of anti-HCV positivity in a Sicilian population with liver diseases].
    Montalto G; Soresi M; Tripi S; Carroccio A; Bascone F; Di Martino D; Bonfissuto G; Notarbartolo A
    Ann Ital Med Int; 1995; 10(2):89-92. PubMed ID: 7619657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
    Lau DT; Hewlett AT
    Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies, sheep cell agglutinins and anti-albumin antibodies in alcoholic liver disease.
    Macgeorge J; Frazer IH; Cunningham A
    J Clin Lab Immunol; 1984 Jan; 13(1):21-4. PubMed ID: 6609235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of antibodies against rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
    Ortona L; Laghi V; Tamburrini E; Troncone L; Bonifazi N; Nervo P; Cauda R
    Clin Exp Immunol; 1983 May; 52(2):437-40. PubMed ID: 6861379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
    Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
    Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [e/Anti-e system in liver disease].
    Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
    Sponseller CA; Bacon BR; Di Bisceglie AM
    Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatopathies associated with chronic carriage of HBs antigen in black African immigrants in France].
    Meyniel D; Santoni JP; Gessain A; Grivaux M; Chatelet F; Pieron R
    Sem Hop; 1983 Oct; 59(35):2465-70. PubMed ID: 6314528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between anti-albumin antibodies and HBsAG in hepatic patients.
    Lenkei R; Babes VT; Dan ME; Mustea A; Dobre I
    J Med Virol; 1977; 1(1):29-34. PubMed ID: 416175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies.
    Değertekin H; Yalçin K; Yakut M
    Turk J Gastroenterol; 2006 Mar; 17(1):25-34. PubMed ID: 16830274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.